02/05/2014
no comments
0
0
US drugs giant Pfizer has raised the price it is offering for the UK’s AstraZeneca to £50 a share, valuing the firm at £63bn.
BBC News – Business
You May Also Be Interested In:
- UK chip giant Arm files for blockbuster US share listing by Craig Taylor
- Made ex-boss says offer to save company ‘rebuffed’ by Craig Taylor
- McDonald's puts up price of cheeseburger for first time in… by Craig Taylor
- Netflix ad-supported service to launch in November by Craig Taylor
- Wegovy: Weight-loss drug firm becomes Europe's most valuable by Craig Taylor
- Crypto giant FTX collapses into bankruptcy by Craig Taylor
0
0
